AGAPE ATP CORPORATION (ATPC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 2.94M USD | Liabilities, Current |
| Cash and equivalents | 45.48K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 21.68K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.94M | $45.48K | (m) | (m) | $21.68K | (m) |
| 2026-03-31 | (m) | $2.74M | $220.78K | (m) | $4.37K | $24.79K | (m) |
| 2025-12-31 | (m) | $2.05M | $140.07K | (m) | $12.31K | $27.39K | (m) |
| 2025-09-30 | (m) | $1.49M | $133.71K | (m) | $7.44K | $39.89K | (m) |
| 2025-06-30 | (m) | $1.20M | $215.97K | (m) | $23.92K | $36.30K | (m) |
| 2025-03-31 | (m) | $1.00M | $578.79K | (m) | $41.44K | $36.70K | (m) |
| 2024-12-31 | (m) | $1.12M | $2.04M | (m) | $53.65K | $46.35K | (m) |
| 2024-09-30 | (m) | $946.89K | $2.72M | (m) | $41.94K | $60.56K | (m) |
| 2024-06-30 | (m) | $810.36K | $3.16M | (m) | $41.66K | $53.44K | (m) |
| 2024-03-31 | (m) | $844.29K | $3.58M | (m) | $37.66K | $56.88K | (m) |
| 2023-12-31 | (m) | $1.07M | $4.83M | (m) | $55.46K | $47.91K | (m) |
| 2023-09-30 | (m) | $974.06K | $311.66K | (m) | $22.72K | $56.78K | (m) |
| 2023-06-30 | (m) | $968.33K | $653.75K | (m) | $5.30K | $66.06K | (m) |
| 2023-03-31 | (m) | $1.05M | $1.12M | (m) | $4.02K | $45.42K | (m) |
| 2022-12-31 | (m) | $1.23M | $1.44M | (m) | $2.83K | $46.28K | (m) |
| 2022-09-30 | (m) | $850.00K | $1.58M | (m) | $1.72K | $275.41K | (m) |
| 2022-06-30 | (m) | $924.47K | $1.81M | (m) | $214.00 | $346.74K | (m) |
| 2022-03-31 | (m) | $1.06M | $2.44M | (m) | $3.36K | $379.96K | (m) |
| 2021-12-31 | (m) | $1.31M | $2.60M | (m) | (m) | $375.54K | (m) |
| 2021-09-30 | (m) | $866.24K | $2.88M | (m) | (m) | $475.51K | (m) |
| 2021-06-30 | (m) | $860.38K | $3.30M | (m) | (m) | $490.27K | (m) |
| 2021-03-31 | (m) | $916.98K | $3.35M | (m) | (m) | $543.79K | (m) |
| 2020-12-31 | (m) | $1.04M | $3.52M | (m) | $172.76K | $589.81K | (m) |
| 2020-09-30 | (m) | $986.85K | $3.34M | (m) | $276.80K | $512.78K | (m) |
| 2020-06-30 | (m) | $1.59M | $3.43M | (m) | $325.43K | $416.63K | (m) |
| 2020-03-31 | (m) | $97.46K | $2.59M | (m) | $523.14K | (m) | (m) |
| 2019-12-31 | (m) | $83.99K | $2.74M | (m) | $520.79K | (m) | (m) |
| 2019-09-30 | (m) | $127.22K | $2.75M | (m) | $628.58K | (m) | (m) |
| 2019-06-30 | (m) | $149.67K | $2.86M | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $91.50K | $3.09M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $241.85K | $3.45M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $541.03K | $3.84M | (m) | $13.26K | (m) | (m) |
| 2018-06-30 | (m) | $29.75K | $3.53M | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $11.61K | $4.11M | (m) | $52.41K | (m) | (m) |
| 2017-12-31 | (m) | $144.29K | $1.86M | (m) | $489.84K | (m) | (m) |
| 2017-09-30 | (m) | $398.15K | $2.16M | (m) | $490.47K | (m) | (m) |
| 2017-06-30 | (m) | $8.10K | $2.31M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $10.00 | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $10.00 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $10.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |